Global AI In Medical Imaging Market 2026-2033 Expected To Reach $20.2 Billion As Cloud Integration And Radiologist Shortages Drive 35.11% CAGR
The global AI in medical imaging market was valued at an estimated USD 1.8 billion in 2025 and is projected to reach USD 20.2 billion by 2033. The market is expected to expand at a compound annual growth rate of 35.11% from 2026 to 2033, supported by growing demand for early and accurate diagnosis, increasing medical imaging volumes, and continued advancements in artificial intelligence and machine learning technologies.
Healthcare providers are adopting AI-powered medical imaging solutions to improve diagnostic accuracy, accelerate image analysis, optimize clinical workflows, and support more informed treatment decisions. These capabilities are becoming increasingly important as hospitals and diagnostic imaging centers manage rising examination volumes and seek to improve operational efficiency without compromising the quality of patient care.
The global shortage of skilled radiologists is also contributing to market expansion. AI-driven imaging platforms can assist clinical teams with image interpretation, case prioritization, anomaly detection, and reporting. Their adoption is expected to increase as healthcare organizations pursue scalable technologies that support radiologists and reduce pressure on diagnostic services.
Integration with picture archiving and communication systems, cloud infrastructure, telemedicine platforms, and remote diagnostic services is further strengthening the role of AI in medical imaging. Cloud-based deployment enables healthcare providers to access advanced imaging capabilities across multiple facilities while supporting collaboration among radiologists, specialists, and care teams. The continued growth of telemedicine is also increasing demand for remote image assessment and centralized diagnostic workflows.
Other important market drivers include advances in clinical decision support, improvements in imaging algorithms, supportive government initiatives, evolving regulatory frameworks, and increased public funding for healthcare AI research. Strategic collaborations among technology companies, medical imaging providers, academic institutions, and healthcare organizations are accelerating product development and clinical validation. These partnerships are expected to expand the availability of AI applications across a broader range of medical specialties and care settings.
Market Segmentation
The report analyzes revenue growth at the global, regional, and country levels and evaluates industry trends across key sub-segments from 2021 to 2033. The market is segmented by technology, application, modality, end-use, and region.
Technology Outlook (Revenue, USD Million, 2021-2033)
- Deep Learning Natural Language Processing (NLP) Others
Deep learning and Natural Language Processing technologies are supporting advances in image analysis, workflow automation, clinical documentation, and diagnostic decision support.
Application Outlook (Revenue, USD Million, 2021-2033)
- Neurology Respiratory and Pulmonary Cardiology Breast Screening Orthopedics Others
The growing use of AI across neurology, cardiology, breast screening, orthopedics, and respiratory and pulmonary imaging reflects the technology's expanding clinical relevance. Applications include disease detection, image classification, measurement automation, risk assessment, and treatment planning.
Modality Outlook (Revenue, USD Million, 2021-2033)
- CT Scan MRI X-rays Ultrasound Nuclear Imaging
AI adoption is increasing across major imaging modalities as providers seek faster interpretation, consistent image quality, and improved identification of clinically significant findings.
End-use Outlook (Revenue, USD Million, 2021-2033)
- Hospitals Diagnostic Imaging Centers Others
Hospitals and diagnostic imaging centers represent significant end-use segments due to their high imaging volumes, investments in digital infrastructure, and need for integrated diagnostic workflows.
Regional Outlook (Revenue, USD Million, 2021-2033)
The report covers North America, Europe, Asia-Pacific, Latin America, and MEA. Country-level analysis includes the U.S., Canada, Mexico, Germany, UK, France, Italy, Spain, Denmark, Sweden, Norway, China, Japan, India, South Korea, Australia, Thailand, Brazil, Argentina, South Africa, Saudi Arabia, UAE, and Kuwait.
Regional market development is influenced by healthcare digitization, AI investment, medical imaging infrastructure, regulatory policies, research activity, and access to skilled clinical professionals. As adoption broadens across established and emerging healthcare markets, AI in medical imaging is positioned to become an increasingly important component of diagnostic care and clinical decision support through 2033.
Companies Featured
- GE HealthCare Microsoft Digital Diagnostics Inc. TEMPUS Butterfly Network, Inc. Advanced Micro Devices, Inc. HeartFlow, Inc. Enlitic, Inc. Canon Medical Systems USA, Inc. Viz.ai, Inc. EchoNous, Inc. HeartVista Inc. Exo Imaging, Inc. Nano-X Imaging Ltd.
For more information about this report visit
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept any
responsibility or liability for the accuracy, content, images, videos,
licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright issues
related to this article, kindly contact the provider above.

Comments
No comment